Drug Policy Provider Comments
We invite our participating physicians and other providers to submit scientific, evidence-based information, professional consensus opinions and other information supported by medical literature relevant to these draft policies for consideration. We receive comments for 45 days from the posting date listed on the document.
Provider-Administered Drug Review Program (Excluding Oncology)
Blue Cross and Blue Shield of Alabama offers a new paperless predetermination service* that will streamline the authorization process for medical drugs (also known as provider-administered drugs).
High-Risk Medications Frequently Asked Questions
Frequently asked questions and answers about the High-Risk Medicaion List.
Drug Guide and Clinical Program Updates